UPDATE — The Efficiency Gap: Five Assets Where Price Has Yet To Reflect Reality

UPDATE — The Efficiency Gap: Five Assets Where Price Has Yet To Reflect Reality Issued on behalf of Oncolytics Biotech Inc. GlobeNewswire December 03, 2025 VANCOUVER, British Columbia, Dec. 03, 2025 (GLOBE NEWSWIRE) — USANewsGroup.com Market Intelligence Brief – Efficient Market Theory often fails in the small-cap sector. In this space, price discovery is slow. […]

Zacks Small-Cap Research Initiates Coverage on Nasdaq listed Blue Gold Limited

(NasdaqGM:BGL),(NasdaqGM:BGLWW), – Zacks Small-Cap Research and Senior Analyst Tom Kerr, CFA, today initiated independent research coverage of Blue Gold Limited – Initiation of Vertically Integrated Gold Fintech Company with A Price Target Of $20.00 NEW YORK, NY, Dec. 03, 2025 (GLOBE NEWSWIRE) — Blue Gold Limited (Nasdaq: BGL) (“Blue Gold” or the “Company”), a next-generation

AVENUE DES CHAMPS-ELYSÉES CELEBRATES THE REVIVAL OF ITS SIGNATURE COCKTAIL: THE “CHAMPS-ÉLYSÉES COCKTAIL” FIRST CREATED IN 1925 WITH COGNAC HENNESSY

1925-2025: A Century of Parisian Art de Vivre Born in the Roaring Twenties, the “Champs-Élysées Cocktail” has, since 1925, embodied the elegance, flair, and joie de vivre that have long defined the world's most celebrated avenue. To mark its 100th anniversary, the avenue's landmark establishments united by the Champs-Élysées Committee, honor this iconic signature drink

With Major Partnerships Stacking Up, SMX Has Become Impossible to Ignore

NEW YORK CITY, NEW YORK / ACCESS Newswire / December 3, 2025 / The market pays attention in strange ways. It can ignore a breakthrough for years, then recognize its value in a single week. SMX (NASDAQ:SMX) has seen that shift firsthand. The company does not comment on price fluctuations, but it acknowledges a clear

Zacks Small-Cap Research Initiates Coverage on Nasdaq listed Blue Gold Limited

Zacks Small-Cap Research Initiates Coverage on Nasdaq listed Blue Gold Limited GlobeNewswire December 03, 2025 – Zacks Small-Cap Research and Senior Analyst Tom Kerr, CFA, today initiated independent research coverage of Blue Gold Limited – Initiation of Vertically Integrated Gold Fintech Company with A Price Target Of $20.00 NEW YORK, NY, Dec. 03, 2025 (GLOBE

Canadian General Investments: Investment Update – Unaudited

(TSX:CGI),(LSE:CGI), TORONTO, Canada, Dec. 03, 2025 (GLOBE NEWSWIRE) — Canadian General Investments, Limited (CGI) (TSX:CGI) (LSE: CGI) reports on an unaudited basis that its net asset value per share (NAV) at November 30, 2025 was $80.73 resulting in year-to-date and 12-month NAV returns, with dividends reinvested, of 18.2% and 13.9%, respectively. These compare with the

Canadian General Investments: Investment Update – Unaudited

Canadian General Investments: Investment Update – Unaudited GlobeNewswire December 03, 2025 TORONTO, Canada, Dec. 03, 2025 (GLOBE NEWSWIRE) — Canadian General Investments, Limited (CGI) (TSX:CGI) (LSE: CGI) reports on an unaudited basis that its net asset value per share (NAV) at November 30, 2025 was $80.73 resulting in year-to-date and 12-month NAV returns, with dividends

/C O R R E C T I O N — Global AI/

In the news release, Global AI and HUMAIN Partner to Accelerate Sovereign AI with Large-Scale NVIDIA-Powered AI Centers, issued 03-Dec-2025 by Global AI over PR Newswire, we are advised by the company that changes have been made. The complete, corrected release follows, with additional details at the end: Global AI and HUMAIN Partner to Accelerate

BGM Expands with the Addition of The Vroman Group, LLP

BGM, a leading full-service accounting, tax, and advisory firm headquartered in Bloomington, Minnesota, is pleased to announce the addition of The Vroman Group, LLP, a well-respected accounting and business consulting firm based in West Des Moines, Iowa. https://mma.prnewswire.com/media/2837945/BGM_Logo.jpg This strategic expansion strengthens BGM's presence in the Midwest and enhances its ability to deliver comprehensive accounting,

ASPN Pharmacies Achieves Surescripts® RxTransfer Certification

ASPN Pharmacies, a leading patient services hub and digital pharmacy provider, is proud to announce it is Surescripts® certified for RxTransfer. https://mma.prnewswire.com/media/2744453/ASPN_Pharmacies_logo_FullColor.jpg Why It Matters:RxTransfer, part of Surescripts E-Prescribing solution, significantly improves interoperability, reduces medication errors, minimizes manual data entry, and accelerates transitions of care-helping pharmacists focus on what matters most: patient care. Ami Patel,

Scroll to Top